CerMed internazionale (telescrivente: GMS).
What it does:
CerMed’s mission is to improve the health of women worldwide by providing quality, high-value medical products that aid in the detection of female reproductive diseases.
Core products and services:
1. The CerScreen system is a Point-of-Care approach a woman can do in the comfort of her home in just a few minutes, replace the laboratory Pap test, which is a form of cervical cancer screening.
Approx. 160 milione Pap Smear procedures are performed annually worldwide, which translates into solo 20% of the target population being serviced.This offers a market opportunity to promote a product that replaces the Pap Test. The predicted market expansion is $20 miliardo.
2. CerMed has developed CerCap, a single use women’s medical device that reduces the risk of both contracting HIV/AIDS and conception.
The product is developed for Women’s Controlled Contraception and HIV/AIDS Protection:
• 33 milioni di persone are living with HIV/AIDS
• 2.7 million new cases are reported per year, oltre 50% in women.
The product has a $40 Billion market potential for the developing world.
CerMed offers two innovative products that can cambiare a woman’s life for the better. The products are revolutionary to a certain extent. Il first product is a system developed to replace the classical Pap Test, which detects cervical cancer. The pap test has limited informational value and is far from being a perfect solution. Il second product is a contraceptive, anti-HIV/AIDS drug. CerMed plans to offer the drug in the developing world, where a $40+ billion sales potential exists, combined with the first product mentioned, CerMed anticipates a $60 miliardo sales projection.